Arrêt de service programmé du vendredi 10 juin 16h jusqu’au lundi 13 juin 9h. Pour en savoir plus
Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France

Tom Woudenberg 1, 2 Stéphane Pelleau 1, 2 Francois Anna 3 Mikael Attia 4 Francoise Donnadieu 1, 2 Alain Gravet 5 Caroline Lohmann 5 Helene Seraphin 6 Raphael Guiheneuf 6 Catherine Delamare 7 Karl Stefic 8 Julien Marlet 8 Etienne Brochot 9, 10 Sandrine Castelain 9, 10 Olivier Augereau 11 Jean Sibilia 12 Francois Dubos 13 Damia Meddour 13 Christele Gras-Le Guen 14 Marianne Coste-Burel 14 Berthe-Marie Imbert-Marcille 14 Anne Chauvire-Drouard 15 Cyril Schweitzer 16 Amelie Gatin 17 Sandra Lomazzi 18 Aline Joulie 19 Herve Haas 19 Aymeric Cantais 20 Frederique Bertholon 20 Marie-France Chinazzo-Vigouroux 8 Mohamed S. Abdallah 21 Laurence Arowas 22 Pierre Charneau 3 Bruno Hoen 23 Caroline Demeret 4 Sylvie Werf 4, 24 Arnaud Fontanet 25, 26, * Michael White 1, 2, *
* Auteur correspondant
1 Epidémiologie et Analyse des Maladies Infectieuses - Infectious Disease Epidemiology and Analytics
Institut Pasteur [Paris]
2 Malaria : parasites et hôtes - Malaria : parasites and hosts
3 Virologie Moléculaire et Vaccinologie / Molecular Virology and Vaccinology
Institut Pasteur [Paris]
4 GMV-ARN (UMR_3569 / U-Pasteur_2) - Génétique Moléculaire des Virus à ARN - Molecular Genetics of RNA Viruses
5 Centre Hospitalier de Mulhouse, site du Hasenrain (Mulhouse)
6 Centre Hospitalier Simone Veil de Beauvais [Beauvais]
7 CHR Metz-Thionville - Centre hospitalier régional Metz-Thionville
8 CHRU Tours - Centre Hospitalier Régional Universitaire de Tours
9 AGIR - Agents infectieux, résistance et chimiothérapie - UR UPJV 4294
10 Laboratoire de Virologie [CHU Amiens]
11 Hôpitaux Civils de Colmar
12 CHU Strasbourg
13 CHRU Lille - Centre Hospitalier Régional Universitaire [Lille]
14 CHU Nantes - Centre hospitalier universitaire de Nantes
15 CIC Nantes - Centre d’Investigation Clinique de Nantes
16 CHRU Nancy - Centre Hospitalier Régional Universitaire de Nancy
17 Service de Pédiatrie [CHRU Nancy]
18 CRB Nancy - Centre de Ressources Biologiques - [Nancy]
19 CHU-Lenval - Hôpitaux Pédiatriques de Nice Lenval
20 CHU de Saint-Etienne - Centre Hospitalier Universitaire de Saint-Etienne
21 ARS - agence régionale de santé Hauts-de-France
22 ICAReB - Investigation Clinique et d’Accès aux Ressources Biologiques (Plate-forme) - Clinical Investigation and Access to BioResources
23 Direction de la recherche médicale de l'Institut Pasteur
24 CNR - Centre National de Référence des virus des infections respiratoires (dont la grippe) - National Reference Center Virus Influenzae [Paris]
25 Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology
26 CNAM - Conservatoire National des Arts et Métiers [CNAM]
Abstract : Background: Children are underrepresented in the COVID-19 pandemic and often experience milder disease than adolescents and adults. Reduced severity is possibly due to recent and more frequent seasonal human coronaviruses (HCoV) infections. We assessed the seroprevalence of SARS-CoV-2 and seasonal HCoV specific antibodies in a large cohort in north-eastern France. Methods: In this cross-sectional seroprevalence study, serum samples were collected from children and adults requiring hospital admission for non-COVID-19 between February and August 2020. Antibody responses to SARS-CoV-2 and seasonal HCoV (229E, HKU1, NL63, OC43) were assessed using a bead-based multiplex assay, Luciferase-Linked ImmunoSorbent Assay, and a pseudotype neutralisation assay. Findings: In 2,408 individuals, seroprevalence of SARS-CoV-2-specific antibodies was 7-8% with three different immunoassays. Antibody levels to seasonal HCoV increased substantially up to the age of 10. Antibody responses in SARS-CoV-2 seropositive individuals were lowest in adults 18-30 years. In SARS-CoV-2 seronegative individuals, we observed cross-reactivity between antibodies to the four HCoV and SARS-CoV-2 Spike. In contrast to other antibodies to SARS-CoV-2, specific antibodies to sub-unit 2 of Spike (52) in seronegative samples were highest in children. Upon infection with SARS-CoV-2, antibody levels to Spike of betacoronavirus OC43 increased across the whole age spectrum. No SARS-CoV-2 seropositive individuals with low levels of antibodies to seasonal HCoV were observed. Interpretation: Our findings underline significant cross-reactivity between antibodies to SARS-CoV-2 and seasonal HCoV, but provide no significant evidence for cross-protective immunity to SARS-CoV-2 infection due to a recent seasonal HCoV infection. In particular, across all age groups we did not observe SARS-CoV-2 infected individuals with low levels of antibodies to seasonal HCoV.
Keywords : COVID-19 SARS-CoV-2 antibody response seasonal coronaviruses sero-epidemiology seroprevalence
Type de document :
Article dans une revue
Liste complète des métadonnées
https://hal-u-picardie.archives-ouvertes.fr/hal-03591559
Contributeur : Louise Dessaivre Connectez-vous pour contacter le contributeur
Soumis le : lundi 28 février 2022 - 17:29:23
Dernière modification le : dimanche 1 mai 2022 - 03:17:53

Fichier

Vignette du document
1-s2.0-S2352396421002887-main....
Publication financée par une institution

Licence

Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

Collections

UP-SCIENCES | UNIV-HESAM | UNIV-PARIS | CNRS | ANR | CNAM | UNIV-NANTES | PASTEUR | AGIR-UPJV | U-PICARDIE | INSERM

Citation

Tom Woudenberg, Stéphane Pelleau, Francois Anna, Mikael Attia, Francoise Donnadieu, et al.. Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France. EBioMedicine, Elsevier, 2021, 70, pp.103495. ⟨10.1016/j.ebiom.2021.103495⟩. ⟨hal-03591559⟩

Exporter

BibTeX TEI DC DCterms EndNote Datacite

Partager

Métriques

Consultations de la notice

28

Téléchargements de fichiers

5